Insulin Pump Therapy: Patient Practices and Glycemic Outcomes
- PMID: 29808716
- PMCID: PMC6232746
- DOI: 10.1177/1932296818778869
Insulin Pump Therapy: Patient Practices and Glycemic Outcomes
Keywords: diabetes; hyperglycemia; hypoglycemia; insulin pump therapy.
Conflict of interest statement
References
-
- Yeh HC, Brown TT, Maruthur N, et al. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med. 2012;157:336-347. - PubMed
-
- Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetes Care. 2015;38:716-722. - PubMed
-
- Ross P, Gray AR, Milburn J, et al. Insulin pump-associated adverse events are common, but not associated with glycemic control, socio-economic status, or pump/infusion set type. Acta Diabetol. 2016;53:991-998. - PubMed
-
- Wen W, Frampton R, Wright K, Fattore S, Shadbolt B, Perampalam S. A pilot study of factors associated with glycaemic control in adults with type 1 diabetes mellitus on insulin pump therapy. Diabet Med. 2016;33:231-234. - PubMed
-
- Deeb A, Abu-Awad S, Abood S, et al. Important determinants of diabetes control in insulin pump therapy in patients with type 1 diabetes mellitus. Diabetes Technol Ther. 2015;17:166-170. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
